Effect of dietary β carotene on cerebral aneurysm and subarachnoid haemorrhage in the brain apo E -/- mice

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 3, 2011, Pages 343-355

  Gopal, K ^a   Nagarajan, P ^b   Avinash Raj, T ^a   Jahan, P ^c   Ganapathy, H S ^d   Mahesh Kumar, M J ^a  

^a CENTRE FOR CELLULAR AND MOLECULAR BIOLOGY   (India)

^b NATIONAL INSTITUTE OF IMMUNOLOGY   (India)

^c OSMANIA UNIVERSITY   (India)

^d KUMAMOTO UNIVERSITY   (Japan)

Author keywords

carotene; Ang II; Apo E mice

Indexed keywords

ANGIOTENSIN II; BETA CAROTENE; CHOLESTEROL; COLONY STIMULATING FACTOR 1; GELATINASE A; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MATRIX METALLOPROTEINASE; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PLASMINOGEN ACTIVATOR INHIBITOR; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL; UROKINASE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ARTERY ANEURYSM; BRAIN INFARCTION SIZE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET SUPPLEMENTATION; FLOW CYTOMETRY; GENE EXPRESSION; HISTOPATHOLOGY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SUBARACHNOID HEMORRHAGE; THERAPY EFFECT;

ANGIOTENSIN II; ANIMALS; APOLIPOPROTEINS E; BETA CAROTENE; BRAIN; DIETARY SUPPLEMENTS; GENE EXPRESSION REGULATION; INTRACRANIAL ANEURYSM; LIPIDS; MACROPHAGES; MICE; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; SUBARACHNOID HEMORRHAGE; VASOCONSTRICTOR AGENTS; VITAMINS;

EID: 82955195911     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0620-7     Document Type: Article

References (20)

1. Aoki T, Kataoka H, Ishibash R, Nozaki K, Egashira K, Hashimoto N (2009) Impact of monocyte chemoattractant protein-1 deficiency on cerebral aneurysm formation. Stroke 40:942-951
2. Horiuchi M, Mogi M, Iwai M (2009) The angiotensin II type 2 receptor in the brain. J Renin Angiotensin Aldosterone Syst 11(1):1-6
3. Saad MA, Abbas AM, Boshra V, Elkhateeb M, Aal A (2010) Effect of angiotensin II type 1 receptor blocker, candesartan, and b1 adrenoceptor blocker, atenolol, on brain damage in ischemic stroke. Acta Physiol Hung 97(2):159-171
4. Lanz TV, Ding Z, Peggy PH, Luo J, Agrawal AN, Srinagesh H, Axtell R, Zhang H, Platten M, Wyss-Coray T, Steinman L (2010) Angiotensin II sustains brain inflammation in mice via TGF-b. J Clin Invest 120(8):2782
5. Chrissobolis S, Faraci FM (2008) The role of oxidative stress and NADPH oxidase in cerebrovascular disease Sophocles. Trends Mol Med 14:495-502
6. Frijns CJM, Kappelle LJ (2002) Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. Stroke 33:2115-2122
7. Del Zoppo G, Ginis I, Hallenbeck JM, Iadecola C, Wang X, Feuerstein GZ (2000) Inflammation and stroke: putative role for cytokines, adhesion molecules and iNOS in brain response to ischemia. Brain Pathol 10:95-112 (Pubitemid 30056398)
8. Fisher M, Lees K, Spence JD (2006) Nutrition and stroke prevention. Stroke 37:2430-2435 (Pubitemid 44337195)
9. Gopal K, Kumar K, Nandini R, Jahan P, Mahesh Kumar MJ (2010) High fat diet containing cholesterol induce aortic aneurysm through recruitment and proliferation of circulating agranulocytes in apoE knock out mice model. J Thromb Thrombolysis 30:154-163
10. Manso H, Krug T, Sobral J, Albergaria I, Gaspar G, Ferro JM, Oliveira SA, Vicente AM (2010) Variants of the Matrix Metalloproteinase-2 but not the Matrix Metalloproteinase-9 genes significantly influence functional outcome after stroke. BMC Med Genet 11:40
11. Jihong Xu, Storer PD, Chavis JA, Racke MK, Drew PD (2005) Agonists for the peroxisome proliferator-activated receptor-a and the retinoid 9 receptor inhibit inflammatory responses of microglia. J Neurosci Res 81:403-411 (Pubitemid 41359295)
12. Kunigal S, Lakka SS, Gondi CS, Estes N, Rao JS (2007) RNAimediated downregulation of urokinase plasminogen activator receptor (uPAR) and matrix metalloprotease-9 (MMP-9) in human breast cancer cells results in decreased tumor invasion, angiogenesis and growth. Int J Cancer 121(10):2307-2316 (Pubitemid 47585614)
13. Hobeika MJ (2007) Matrix metalloproteinases in peripheral vascular disease. J Vasc Surg 45:849-857 (Pubitemid 46483940)
14. Lijnen HR, Hoef VB (1998) Lupu F.Function of the plasminogen/plasmin and matrix metalloproteinase systems after vascular injury in mice with targeted inactivation of fibrinolytic system genes. Arterioscler Thromb Vasc Biol 18:1035-1045 (Pubitemid 28323587)
15. Knox JB, Sukhova GK, Whittemore AD, Libby P (1997) Evidence for altered imbalance between matrix metalloproteinases and their inhibitors in human aortic diseases. Circulation 5:205-212 (Pubitemid 27029964)
16. Heo JH, Lucero J, Abumiya T, Koziol JA, Copeland BR, Zoppo GJ (1999) Matrix metalloproteinases increase very early during experimental focal cerebral ischemia. J Cereb Blood Flow Metab 19:624-633 (Pubitemid 30161214)
17. Yong VW, Power C, Forsyth P, Edward R (2001) Metalloproteinases in biology and pathology of the nervous system. Nat Rev Neurosci 2:502-511 (Pubitemid 33676585)
18. Gill SE, Kassim SY, Birkland TP, Parks WC (2010) Mouse models of MMP and TIMP function. Methods Mol Biol 622:31-52
19. Gallacher J, Bayer A, Lowe G, Fish M, Pickering J, Pedro S, Dunstan F, White J, Yarnell J, Ben-Shlomo Y (2010) Is sticky blood bad for the brain? Hemostatic and inflammatory systems and dementia in the caerphilly prospective study. Arterioscler Thromb Vasc Biol 30:599-604
20. Zhang FY, Chen XC, Ren HM, Bao WM (2006) Effects of ischemic preconditioning on blood-brain barrier permeability and MMP-9 expression of ischemic brain. Neurol Res 28:21-24